Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;18(8):1166-1175.
doi: 10.1158/1541-7786.MCR-19-1262. Epub 2020 May 20.

Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival

Liya Xu #  1   2   3 , Ashley Polski #  1   4 , Rishvanth K Prabakar  5 , Mark W Reid  1 , Patricia Chevez-Barrios  6 , Rima Jubran  7 , Jonathan W Kim  1   4 , Peter Kuhn  2   3   8   9   10 , David Cobrinik  1   3   4   8   11 , James Hicks  2   8 , Jesse L Berry  12   3   4   8
Affiliations

Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival

Liya Xu et al. Mol Cancer Res. 2020 Aug.

Abstract

Aqueous humor contains tumor-derived cell-free DNA (cfDNA) and can serve as a liquid biopsy for retinoblastoma. We previously associated somatic copy-number alteration (SCNA) 6p gain with a 10-fold increased risk of enucleation. Here we provide a 2-year update to further explore 6p gain as a prognostic biomarker for ocular survival. Patients diagnosed with retinoblastoma from December 2014 to July 2019 from whom aqueous humor was sampled were included. cfDNA was extracted and shallow whole-genome sequencing performed to identify highly recurrent retinoblastoma SCNAs (gain of 1q, 2p, 6p, loss of 13q, 16q). 116 aqueous humor samples from 50 eyes of 46 patients were included: 27 eyes were salvaged, 23 were enucleated. Highly recurrent retinoblastoma SCNAs were found in 66% eyes. 6p gain was the most prevalent SCNA (50% eyes). It was particularly more prevalent in enucleated eyes (73.9%) than in salvaged eyes (29.6%; P = 0.004). 6p gain in aqueous humor cfDNA portended nearly 10-fold increased odds of enucleation (OR = 9.87; 95% confidence interval = 1.75-55.65; P = 0.009). In the enucleated eyes, 6p gain was associated with aggressive histopathologic features, including necrosis, higher degrees of anaplasia, and focal invasion of ocular structures. With extended follow-up and nearly double the aqueous humor samples, we continue to demonstrate 6p gain as a potential prognostic biomarker for retinoblastoma. IMPLICATIONS: Aqueous humor is a high-yield source of tumor-derived DNA in retinoblastoma eyes. Detection of 6p gain in the aqueous humor allows for targeted, patient-centered therapies based on this molecular prognostic marker. Prospective, multicenter studies with aqueous humor sampled from all eyes at diagnosis are warranted to validate these findings.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Drs. Berry, Xu, and Hicks have filed a provisional patent application entitled, Aqueous Humor Cell Free DNA for Diagnostic and Prognostic Evaluation of Ophthalmic Disease. Otherwise the authors declare no potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Flow diagram summarizing the treatments given and the presence or absence of 6p gain in each treatment group.
Figure 2.
Figure 2.
Kaplan-Meier analysis demonstrating a 3.8-times greater risk of enucleation in eyes with 6p gain compared to eyes without a 6p gain after 1 year.
Figure 3.
Figure 3.
A, Composite somatic copy number alteration (SCNA) profile of cell-free DNA (cfDNA) sampled from the aqueous humor (AH) of enucleated (Enuc., red) and salvaged (Salv., blue) eyes. B, Box plots demonstrating the range of ratio to median amplitudes for SCNAs in enucleated (Enuc.) and salvaged (Salv.) eyes (median, black bar; mean, green bar). The median of the ratio to the median amplitude of chromosome 6p gain is significantly greater in enucleated eyes compared to salvaged eyes (P = 0.005).
Figure 4.
Figure 4.
Chromosome 6 heatmap showing the lengths of 6p gain (red) in 25 eyes with retinoblastoma. Most eyes demonstrated a gain of the entire 6p arm. The minimum region of gain (MRG) was localized to a 19 Mbp region that included a gain of DEK (Case 11).
See this image and copyright information in PMC

References

    1. Fernandes AG, Pollock BD, Rabito FA. Retinoblastoma in the United States: A 40-Year Incidence and Survival Analysis. J Pediatr Ophthalmol Strabismus 2018;55(3):182–8 doi 10.3928/01913913-20171116-03. - DOI - PubMed
    1. Shields JA, Shields CL, Ehya H, Eagle RC, De Potter P. Fine-needle aspiration biopsy of suspected intraocular tumors. The 1992 Urwick Lecture. Ophthalmology 1993;100(11):1677–84. - PubMed
    1. Karcioglu ZA, Gordon RA, Karcioglu GL. Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology 1985;92(12):1763–7 doi 10.1016/s0161-6420(85)34105-2. - DOI - PubMed
    1. Karcioglu ZA. Fine needle aspiration biopsy (FNAB) for retinoblastoma. Retina 2002;22(6):707–10. - PubMed
    1. Eide N, Syrdalen P, Walaas L, Hagmar B. Fine needle aspiration biopsy in selecting treatment for inconclusive intraocular disease. Acta Ophthalmol Scand 1999;77(4):448–52. - PubMed

Publication types

MeSH terms